quinazolines has been researched along with Acinetobacter Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Chen, H; Dong, L; Hong, W; Hu, X; Ren, Y; Sun, P; Wang, H; Wu, H; Xiao, Z; Xie, C; Yang, X; You, X; Zhang, J; Zhao, Z | 1 |
| Bohan, LE; Chaiyen, P; Leartsakulpanich, U; Nicholson, ES; Prasopporn, S; Songsungthong, W; Yongkiettrakul, S | 1 |
| Barber, MM; Burda, WN; Flanigan, DL; Fleeman, R; Manetsch, R; Shaw, LN; Van Horn, KS | 1 |
3 other study(ies) available for quinazolines and Acinetobacter Infections
| Article | Year |
|---|---|
The Anti-Multidrug-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Quinazolines; Tetrahydrofolate Dehydrogenase | 2022 |
Diaminoquinazoline MMV675968 from Pathogen Box inhibits Acinetobacter baumannii growth through targeting of dihydrofolate reductase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Quinazolines; Tetrahydrofolate Dehydrogenase | 2019 |
Characterizing the Antimicrobial Activity of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Cell Line, Tumor; Cell Survival; Diamines; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Folic Acid Antagonists; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Peritonitis; Quinazolines; Tetrahydrofolate Dehydrogenase | 2017 |